Gerd Fricker

Title: Gerd Fricker: Innovator in Pharmaceutical Formulations

Introduction

Gerd Fricker is a notable inventor based in Staufen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. With a total of 3 patents, Fricker's work focuses on enhancing the delivery and absorption of pharmaceutical compounds.

Latest Patents

Fricker's latest patents include groundbreaking pharmaceutical compositions that utilize macrolide compounds, such as rapamycin. These formulations are designed as emulsion preconcentrates or microemulsion preconcentrates for oral administration. The carrier medium for these rapamycin compounds consists of a hydrophilic phase, a lipophilic phase, and a surfactant. This innovative composition is stable and provides high absorption efficiency, which is crucial for effective medication delivery.

Career Highlights

Gerd Fricker is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on the development of advanced pharmaceutical formulations that improve patient outcomes. His expertise in this area has positioned him as a key figure in pharmaceutical innovation.

Collaborations

Fricker has collaborated with several talented professionals in his field, including Barbara Haeberlin and Armin Meinzer. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Gerd Fricker's contributions to pharmaceutical formulations demonstrate his commitment to innovation in healthcare. His work continues to impact the industry positively, enhancing the effectiveness of drug delivery systems.